Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 11, 2022

SELL
$0.63 - $1.59 $9,765 - $24,645
-15,500 Closed
0 $0
Q3 2021

Oct 21, 2021

BUY
$2.15 - $3.82 $33,325 - $59,210
15,500 New
15,500 $34,000
Q3 2021

Oct 13, 2021

SELL
$2.15 - $3.82 $33,325 - $59,210
-15,500 Closed
0 $0
Q4 2019

Feb 06, 2020

BUY
$3.5 - $10.35 $35 - $103
10 Added 0.06%
15,500 $56,000
Q3 2019

Oct 09, 2019

BUY
$7.03 - $9.7 $281 - $388
40 Added 0.26%
15,490 $128,000
Q2 2019

Jul 09, 2019

BUY
$7.36 - $11.26 $2,134 - $3,265
290 Added 1.91%
15,450 $133,000
Q1 2019

May 02, 2019

SELL
$9.08 - $11.84 $454 - $592
-50 Reduced 0.33%
15,160 $162,000
Q4 2018

Jan 31, 2019

BUY
$6.39 - $16.99 $2,811 - $7,475
440 Added 2.98%
15,210 $133,000
Q3 2018

Nov 08, 2018

BUY
$16.52 - $24.82 $9,912 - $14,892
600 Added 4.23%
14,770 $248,000
Q2 2018

Jul 31, 2018

BUY
$14.31 - $21.75 $15,168 - $23,055
1,060 Added 8.09%
14,170 $297,000
Q1 2018

Apr 16, 2018

SELL
$16.09 - $23.07 $54,706 - $78,438
-3,400 Reduced 20.59%
13,110 $211,000
Q4 2017

Feb 05, 2018

BUY
$13.36 - $20.73 $18,971 - $29,436
1,420 Added 9.41%
16,510 $313,000
Q3 2016

Oct 25, 2017

BUY
N/A
15,090
15,090 $212,000

Others Institutions Holding SPPI

# of Institutions
1
Shares Held
115K
Call Options Held
0
Put Options Held
0

About SPECTRUM PHARMACEUTICALS INC


  • Ticker SPPI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,164,000
  • Description
  • Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...
More about SPPI
Track This Portfolio

Track Crossmark Global Holdings, Inc. Portfolio

Follow Crossmark Global Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crossmark Global Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Crossmark Global Holdings, Inc. with notifications on news.